# Cost-effectiveness of CYP2C19-guided antiplatelet therapy in patients with acute coronary syndrome and percutaneous coronary intervention informed by real-world data

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/cost-effectiveness-of-cyp2c19-guided-antiplatelet-therapy-in-patients-with-acute/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Nita A. Limdi,Larisa H. Cavallari,Craig R. Lee,William B. Hillegass,Ann Holmes,Todd C. Skaar,Maria Pisu,Chrisly Dillon,Amber L. Beitelshees,Philip E. Empey,Julio D. Duarte,Vakaramoko Diaby,Yan Gong,Julie A. Johnson,John A. Graves,Shawn Garbett,Zilu Zhou,Josh F. Peterson,on behalf of Implementing GeNomics In pracTicE (IGNITE) Network Pharmacogenetic Working Group (IGNITE-PGx) |
| Citations | 47 |
| DOI | 10.1038/s41397-020-0162-5 |
| Fields | Economics, Econometrics and Finance,Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.ncbi.nlm.nih.gov/pmc/articles/7417282 |
| OpenAlex ID | https://openalex.org/W3004931634 |
| PMID | 32042096 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Vakaramoko Diaby](https://scholariq.org/researchers/vakaramoko-diaby/)

## Paper primary topic

- [Antiplatelet Therapy and Cardiovascular Diseases](https://scholariq.org/topics/antiplatelet-therapy-and-cardiovascular-diseases/)

## Paper topics

- [Antiplatelet Therapy and Cardiovascular Diseases](https://scholariq.org/topics/antiplatelet-therapy-and-cardiovascular-diseases/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.